2213408-17-2

HYNIC-PSMA is a ligand for molecular imaging of tumors. Hynic-psma consists of two components: HYNIC (6-hydrazinonicotinamide) and PSMA (Prostate-Specific Membrane Antigen). HYNIC is a compound used to attach radioactive isotopes to targeted molecules, such as 188Re-HYNIC-PSMA. PSMA is a membrane antigen that is specifically expressed on the surface of prostate cancer cells. HYNIC-PSMA can be used in prostate cancer research[1]. HYNIC-PSMA can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).

[1] Hadisi M, et al. Preclinical evaluation of 188 Re-HYNIC-PSMA as a novel therapeutic agent[J]. Journal of Radioanalytical and Nuclear Chemistry, 2022, 331(2): 841-849.